Science Explorer Interactive view Map
Company · Seoul · South Korea

Bio Pharm Dongsung (South Korea)

Research works
29
▼ 6% vs 2013–17
Citations
439
15.2 per fractional work
Top-10% rate
36.4%
record average 16.5%
Open access
66%
world 28%

Not ranked overall: Bio Pharm Dongsung (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.99× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.80× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.78× its world share, 0 worksImmunology and Micro…Neuroscience: 3.63× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.69× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.50× its world share, 0 worksChemistryEngineering: 1.06× its world share, 2 worksEngineeringMaterials Science: 0.90× its world share, 0 worksMaterials ScienceMedicine: 2.59× its world share, 7 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.7×. Every wedge is a field page.

Which keywords describe research at Bio Pharm Dongsung (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Photodynamic Therapy, Reactive Oxygen Species, Oxidative Stress, Antimicrobial, Cancer Treatment, Photosensitizers and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Nanoparticles6▲ 15×4 topics
  2. Photodynamic Therapy6▲ 122×3 topics
  3. Reactive Oxygen Species5▲ 38×2 topics
  4. Oxidative Stress4▲ 7.3×13 topics
  5. Antimicrobial4▲ 47×3 topics
  6. Cancer Treatment3▲ 41×1 topic
  7. Photosensitizers3▲ 445×1 topic
  8. Immunotherapy3▲ 15×3 topics
  9. Tumor Targeting3▲ 71×2 topics
  10. Fluorescence Imaging2▲ 73×1 topic
  11. Inflammation2▲ 3.5×10 topics
  12. Photothermal Therapy2▲ 98×1 topic
  13. Antioxidant2▲ 9.0×8 topics
  14. Antioxidants2▲ 14×4 topics
  15. Matrix Metalloproteinases1▲ 30×2 topics
  16. Skin Cancer1▲ 67×1 topic
  17. UV Radiation1▲ 87×1 topic
  18. Antioxidant Activity1▲ 6.9×4 topics
  19. Secularism1▲ 32×2 topics

Which research topics does Bio Pharm Dongsung (South Korea) publish most on?

By volume in 2022–2025: Photodynamic Therapy Research Studies, Nanoplatforms for cancer theranostics, Skin Protection and Aging and Photoacoustic and Ultrasonic Imaging.

  1. 1 Photodynamic Therapy Research Studies Pulmonary and Respiratory Medicine 2 works
  2. 2 Nanoplatforms for cancer theranostics Biomedical Engineering 2 works
  3. 3 Skin Protection and Aging Dermatology 1 works
  4. 4 Photoacoustic and Ultrasonic Imaging Biomedical Engineering 0 works
  5. 5 Medicinal Plants and Neuroprotection Complementary and alternative medicine 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Retinoids in leukemia and cellular processes Molecular Biology 0 works
  8. 8 Click Chemistry and Applications Organic Chemistry 0 works
  9. 9 Polysaccharides and Plant Cell Walls Plant Science 0 works
  10. 10 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available66.0%not open34.0%

World: 28% of research is openly available.

with international co-authors10.5%domestic only89.5%

World: 19% is written across borders.

How has Bio Pharm Dongsung (South Korea)'s research output changed?

Output in 2018–2022 was 6% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seoul

All research institutions in Seoul

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.